DK2027263T3 - Fremgangsmåde til at adskille og bestemme den virale belastning i en pancreatinprøve - Google Patents

Fremgangsmåde til at adskille og bestemme den virale belastning i en pancreatinprøve

Info

Publication number
DK2027263T3
DK2027263T3 DK07729324.9T DK07729324T DK2027263T3 DK 2027263 T3 DK2027263 T3 DK 2027263T3 DK 07729324 T DK07729324 T DK 07729324T DK 2027263 T3 DK2027263 T3 DK 2027263T3
Authority
DK
Denmark
Prior art keywords
separating
determining
viral load
pancreatin
assay
Prior art date
Application number
DK07729324.9T
Other languages
English (en)
Inventor
Dietmar Becher
Leopold Doehner
Martin Frink
Frauke Rueffer
Original Assignee
Abbott Products Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Products Gmbh filed Critical Abbott Products Gmbh
Application granted granted Critical
Publication of DK2027263T3 publication Critical patent/DK2027263T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Sampling And Sample Adjustment (AREA)
DK07729324.9T 2006-05-22 2007-05-21 Fremgangsmåde til at adskille og bestemme den virale belastning i en pancreatinprøve DK2027263T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06114329 2006-05-22
PCT/EP2007/054880 WO2007135125A1 (en) 2006-05-22 2007-05-21 Process for separating and determining the viral load in a pancreatin sample

Publications (1)

Publication Number Publication Date
DK2027263T3 true DK2027263T3 (da) 2012-10-22

Family

ID=36694476

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07729324.9T DK2027263T3 (da) 2006-05-22 2007-05-21 Fremgangsmåde til at adskille og bestemme den virale belastning i en pancreatinprøve

Country Status (16)

Country Link
EP (1) EP2027263B1 (da)
JP (1) JP5101604B2 (da)
KR (1) KR101426098B1 (da)
CN (1) CN101448935B (da)
AU (1) AU2007253380B2 (da)
BR (1) BRPI0712569B8 (da)
CA (1) CA2653127C (da)
DK (1) DK2027263T3 (da)
ES (1) ES2391389T3 (da)
IL (1) IL194965A (da)
MX (1) MX2008014763A (da)
PL (1) PL2027263T3 (da)
PT (1) PT2027263E (da)
RU (1) RU2466187C2 (da)
UA (1) UA94945C2 (da)
WO (1) WO2007135125A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE031042T2 (en) 2005-07-29 2017-06-28 Abbott Laboratories Gmbh Methods for producing pancreatin powder with low viral content
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
KR101562682B1 (ko) * 2007-11-15 2015-10-22 애보트 래버러토리즈 게엠베하 판크레아틴 샘플내의 바이러스 로드의 분리 및 정량을 위한 신규방법
SG11201405185PA (en) * 2012-03-13 2014-10-30 Emd Millipore Corp Use of centrifugation-aided infection to increase virus titer
CN112941026B (zh) * 2021-01-27 2023-03-31 上海交通大学 基于密度梯度离心提取细胞内体的方法
CN114672465B (zh) * 2022-04-15 2024-04-19 牧原食品股份有限公司 猪德尔塔冠状病毒的分离方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956483A (en) * 1968-10-24 1976-05-11 Wilson Pharmaceutical & Chemical Corporation Preparing pancreatin
JPS4936886A (da) * 1972-08-15 1974-04-05
AU653337B2 (en) * 1990-04-16 1994-09-29 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5686238A (en) * 1992-02-10 1997-11-11 Baxter International Inc. Method and device for testing blood units for viral contamination
US6632648B1 (en) * 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US5861291A (en) * 1997-02-24 1999-01-19 Biozymes Inc. Method for producing pancreatin which contains low amounts of residual organic solvent and product thereof
DE19856415C2 (de) * 1998-12-08 2001-06-07 Thomas Fenner Verfahren zur Reinigung bzw. Isolierung viraler Nukleinsäuren
GB0216002D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
JP4185412B2 (ja) * 2003-07-10 2008-11-26 東芝テック株式会社 決済処理装置
ITMI20040891A1 (it) * 2004-05-04 2004-08-04 Ibsa Inst Biochimique Sa Nuovo metodo per la partizione ed inattivazione di contaminanti virali e prionici

Also Published As

Publication number Publication date
AU2007253380A1 (en) 2007-11-29
JP2009537163A (ja) 2009-10-29
BRPI0712569B1 (pt) 2019-06-25
BRPI0712569B8 (pt) 2021-07-27
WO2007135125A1 (en) 2007-11-29
EP2027263B1 (en) 2012-07-11
IL194965A0 (en) 2009-08-03
KR101426098B1 (ko) 2014-08-06
EP2027263A1 (en) 2009-02-25
CN101448935B (zh) 2012-02-01
CA2653127A1 (en) 2007-11-29
PL2027263T3 (pl) 2013-01-31
IL194965A (en) 2013-10-31
HK1129236A1 (en) 2009-11-20
KR20090010118A (ko) 2009-01-28
RU2008150623A (ru) 2010-06-27
CN101448935A (zh) 2009-06-03
UA94945C2 (ru) 2011-06-25
JP5101604B2 (ja) 2012-12-19
CA2653127C (en) 2015-09-15
AU2007253380B2 (en) 2013-03-14
MX2008014763A (es) 2008-11-28
RU2466187C2 (ru) 2012-11-10
ES2391389T3 (es) 2012-11-23
BRPI0712569A2 (pt) 2012-11-20
PT2027263E (pt) 2012-09-12

Similar Documents

Publication Publication Date Title
EP1959182A4 (en) FAST CONNECTOR AND INSPECTION DEVICE
FR25C1034I1 (fr) Anticorps ameliores selectifs de protofibrilles et leur utilisation
DK2027263T3 (da) Fremgangsmåde til at adskille og bestemme den virale belastning i en pancreatinprøve
EP1963502A4 (en) COMBINATIONS AND METHOD FOR USE OF AN IMMUNOMODULATIVE OLIGODESOXYNUCLEOTIDE
EP1743019A4 (en) MICROFLUIDIC CHEMOSTAT
EP1824796A4 (en) PROTEIN SKELETONS AND USES THEREOF
EP1812062A4 (en) ANTI-ADDL ANTIBODIES AND ITS USES
NO20082454L (no) Anti-alfa2 integrin antistoffer og deres anvendelser
EP1954140A4 (en) GLYCERINLEVULINATE CHAINS AND ITS USE
EP1996220A4 (en) UNSTRUCTURED RECOMBINANT POLYMERS AND USES THEREOF
EP1711165A4 (en) MEMBRANE SCAFFOLD PROTEINS
EP1895838A4 (en) COMPOSITIONS AND METHODS
FI20080423L (fi) Biologisten komponenttien rikastusyksikkö ja rikastusmenetelmä
EP2061884A4 (en) SENSOR PROTEINS AND TEST PROCEDURES THEREFOR
NO20054709L (no) Sammenfoyningssystem og anvendelse av dette
DE602005014701D1 (de) Verbinderbefestigungseinrichtung und solcher Verbinder
DE502006007362D1 (de) System zur Erkennung und Verwaltung von Paletten
EP1824467A4 (en) Apogossypolone and the uses thereof
DE602005007987D1 (de) achtelung und -entschachtelung
BRPI0716209A2 (pt) Proteína de alimento e interação carregada de emulsificante
DE602006003063D1 (de) Tripeptid- und tetrapeptidsulfone
EP1928496A4 (en) C / CLP ANTAGONISTS AND METHOD OF USE
EP1753468A4 (en) CARBORANYLPORPHYRINE AND ITS USES
FI20055682A0 (fi) Läpivientiosa sekä menetelmä
FI20041220L (fi) Uusi lakkaasientsyymi ja sen käyttö